Dosage optimization of treatments using population pharmacokinetic modeling and simulation

M Guidi, M Arab-Alameddine, M Rotger, M Aouri… - Chimia, 2012 - ojs.chimia.ch
Pharmacokinetic variability in drug levels represent for some drugs a major determinant of
treatment success, since sub-therapeutic concentrations might lead to toxic reactions …

Application and impact of population pharmacokinetics in the assessment of antiretroviral pharmacotherapy

JS Barrett, L Labbé, M Pfister - Clinical pharmacokinetics, 2005 - Springer
Population pharmacokinetics has been an important technique used to explore and define
relevant sources of variation in drug exposure and response in patient populations. This has …

Practical therapeutic drug management in HIV‐infected patients: use of population pharmacokinetic models supplemented by individualized Bayesian dose …

M Neely, R Jelliffe - The Journal of Clinical Pharmacology, 2008 - Wiley Online Library
Individualized, model‐based, target‐oriented optimal concentration‐controlled dosing of HIV
medications can be beneficial to patients for whom there are limited dosing guidelines, such …

Pragmatic approach for interpreting antiretroviral drug concentrations based on a systematic review of population pharmacokinetic studies

M Arab-Alameddine, T Buclin, M Guidi… - … Approach Group in …, 2012 - serval.unil.ch
Objectives: The study objective was to derive reference pharmacokinetic curves of
antiretroviral drugs (ART) based on available population pharmacokinetic (Pop-PK) studies …

Successful projection of the time course of drug concentration in plasma during a 1‐year period from electronically compiled dosing‐time data used as input to …

B Vrijens, E Tousset, R Rode, R Bertz… - The journal of …, 2005 - Wiley Online Library
Pharmacokinetic studies rely on blood sampling at times relative to predefined dosing
intervals. Intensive sampling is often done under direct observation of dose taking, which …

Population pharmacokinetics of nevirapine in Thai HIV-infected patients

T Wattanakul, A Avihingsanon, W Manosuthi… - Antiviral …, 2014 - journals.sagepub.com
Background Nevirapine-based antiretroviral therapy is widely used as a first-line treatment
for HIV-infected patients in resource-limited settings. Nevirapine plasma concentration has …

Kinetic nomograms assist individualization of drug regimens

H Marouani, A Zografidis, A Iliadis - Clinical pharmacokinetics, 2011 - Springer
Abstract Background and Objectives: Therapeutic drug monitoring is applied to a range of
drugs. To predict an appropriate dosing regimen, models based on Bayesian techniques …

Fundamentals of population pharmacokinetic modelling: validation methods

CMT Sherwin, TKL Kiang, MG Spigarelli… - Clinical …, 2012 - Springer
Population pharmacokinetic modelling is widely used within the field of clinical
pharmacology as it helps to define the sources and correlates of pharmacokinetic variability …

Population pharmacokinetics of nevirapine in Malaysian HIV patients: a non-parametric approach

S Mustafa, WNW Yusuf, JB Woillard, TS Choon… - European journal of …, 2016 - Springer
Aims Nevirapine is the first non-nucleoside reverse-transcriptase inhibitor approved and is
widely used in combination therapy to treat HIV-1 infection. The pharmacokinetics of …

Comparison of population pharmacokinetics based on steady-state assumption versus electronically monitored adherence to lopinavir, atazanavir, efavirenz, and …

A Fuchs, A Rotzinger, M Cavassini… - Therapeutic drug …, 2016 - journals.lww.com
Background: Population pharmacokinetic (PopPK) analyses often rely on steady state and
full adherence to prescribed dosage regimen assumptions from data gathered during …